Roll over image to zoom in
SoviHep V (EPCLUSA) Sofosbuvir/Velpatasvir online
$259.00
Status: In stock
A fixed-dose combination medicine combining sofosbuvir 400 mg and velpatasvir 100 mg for the treatment of chronic hepatitis C (genotypes 1 to 6) in adults. It is used in patients without cirrhosis or with compensated cirrhosis, and together with ribavirin when cirrhosis is decompensated.
SoviHep V, also known as “EPCLUSA®, Sofosvel, MyHep All, Hepcvel, Velasof，Velpaclear, Resof Total” is a fixed dose combination medication for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1, 2, 3, 4, 5, or 6 infections without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis. It combines Sofosbuvir 400mg and velpatasvir 100mg. It is more than 90% effective for hepatitis C. Sofosbuvir 400mg/Velpatasvir 100 mg’s brand name is EPCLUSA® by Gilead. SoviHep V is a generic Hepatitis C prescription medicine from Zydus, which is one of the biggest pharmaceutical company in India.
Related products
Recently Viewed Products
